|
|||
|
Journal
Alzheimer s & Dementia
Method of Research
Data/statistical analysis
Subject of Research
People
Article Title
Predictive metabolic networks reveal sex and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer’s Disease
Article Publication Date
28-Apr-2022
COI Statement
RC is the founder of INTelico Therapeutics LLC and co-founder of PATH Biotech LLC. RKD in an inventor on a series of patents on use of metabolomics for the diagnosis and treatment of CNS and other diseases and holds founding equity in Metabolon Inc., Chymia LLC and PsyProtix.